Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:221-222 (3 February), doi:10.1136/bmj.39108.396852.1F
| The first 150 words of the full text of this article appear below. |
Lieberman and First make the case against renaming schizophrenia on the grounds that changing the term would not change the stigma attached to the underlying condition.1 Yet renaming is a key strategy used by marketing and public relations industries to improve image, alongside attitude change and education.
But what should it be replaced with? One of the conclusions emerging from the "Deconstructing psychosis" conference, part of the DSM-V Prelude project was for replacing the current categories with a general psychosis syndrome.2 However, this would increase still further the heterogeneity that currently bedevils biological and psychosocial research, clinical practice, and resource management, when differentiation is really needed.
Trauma has recently been recognised as relevant to a significant group of patients with this diagnosis.3 Since the 1950s, a new group has also been included to broaden the diagnosis further: those in whom there is an association with hallucinogenic drugs.4 Renaming and differentiation
David G Kingdon, Professor of mental healthcare delivery1, Yoshihiro Kinoshita, PhD student1, Farooq Naeem, PhD student1, Maged Swelam, honorary lecturer1, Lars Hansen, consultant psychiatrist2, Selveraj Vincent, specialist registrar2, Shanaya Rathod, consultant psychiatrist3
1 University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, 2 Hampshire Partnership Trust, Southampton SO40 2RZ, 3 Hampshire Partnership NHS Trust, Tadley RG26 3HX
dgk@soton.ac.uk
Read all Rapid Responses